Meet the JCC Authors

Dear ECCO friends and family, Welcome to this stimulating discussion with Dr. Alejandra Carriles and Dr. Benedetta Ricchi authors of the exciting paper “From Pharmaceutical to Biophysical Therapies: New Horizons in Inflammatory Bowel Disease Management”. We had a great time conversing about what biophysical therapies might be used in IBD patient management, where these may fit in the current therapeutic landscape based on the evidence available and what made them explore this not well-known area of treatment.

Dear ECCO Friends and Family, In this episode of ECCO News “Meet the JCC Plus Authors”, we speak with Dr. Thea Helm Wiken and Dr. Karoline Anisdahl about their recent study comparing vedolizumab and ustekinumab in TNF inhibitor–experienced ulcerative colitis patients. Drawing on real-world data and a therapeutic drug monitoring approach, the study provides valuable insights into treatment effectiveness, timing of response, and the role of dose optimization in clinical practice.

Dear ECCO Friends and Family, In this new episode of Meet the JCC Authors, I had the pleasure of speaking with Dr. Sudheer K. Vuyyuru about his recent publication in the Journal of Crohn’s and Colitis, titled: "Day 3 Oxford Criteria Predict Steroid Non-response for Acute Severe Ulcerative Colitis in the Post Biologic Era."

Dear ECCO friends and family, welcome to this interesting discussion with Dr. Tian Hong Wu first author of the exciting paper “Natural History of Crohn’s Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018”.

Dear ECCO friends and family, welcome to this interesting discussion with Dr. Tian Hong Wu first author of the exciting paper “Natural History of Crohn’s Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018”.

Dear ECCO colleagues We are delighted to bring a different colour to our Autumn edition of ECCO News interview corner as we meet and get to know another talented JCC author.

Dear ECCO Friends, Welcome to this new episode of the Meet the JCC Authors Podcast! Here, we interview the rising star of intestinal ultrasound (IUS), Michael Dolinger from Mount Sinai Hospital (NY, US), about his recent article in JCC entitled: “Early intestinal ultrasound response to biologic therapy predicts endoscopic remission in children with ileal Crohn's Disease: Results from the Prospective Super Sonic Study”.